导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 26.75% | 164/1050 |
| 近一周 | -0.20% | 466/1104 |
| 近一月 | -7.86% | 790/1103 |
| 近一季 | -8.21% | 553/1094 |
| 近半年 | 24.54% | 150/1074 |
| 近一年 | 36.10% | 132/1020 |
| 近两年 | 199.90% | 63/926 |
| 近三年 | 213.39% | 20/834 |
| 成立以来 | 469.58% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-1.39% 581/1070 |
52.94% 217/1101 |
- - |
- - |
| 2025 | 82.59% 34/1065 |
-2.89% 946/1014 |
10.06% 102/1038 |
66.43% 18/1050 |
2.65% 265/1065 |
| 2024 | 36.13% 10/1011 |
13.95% 7/960 |
10.54% 13/983 |
2.82% 922/991 |
5.11% 134/1011 |
| 2023 | -30.32% 810/952 |
-3.98% 769/880 |
-1.17% 247/895 |
-20.80% 869/915 |
-7.29% 703/952 |
| 2022 | -22.24% 417/867 |
-18.91% 464/773 |
15.91% 104/806 |
-7.85% 134/845 |
-10.21% 790/867 |
| 2021 | 51.91% 13/740 |
-14.67% 543/580 |
59.53% 2/659 |
16.05% 30/704 |
-3.84% 563/740 |
| 2020 | 104.90% 21/554 |
0.91% 139/419 |
26.82% 165/466 |
11.43% 220/517 |
43.69% 7/554 |
| 2019 | 71.23% 34/410 |
37.48% 100/1149 |
-2.71% 563/1231 |
11.51% 88/390 |
14.81% 57/410 |
| 2018 | -29.88% 209/349 |
- - |
- - |
- - |
-8.01% 153/1080 |
| 2017 | 12.10% 123/285 |
- - |
- - |
- - |
- - |
| 2016 | -16.79% 100/205 |
- - |
- - |
- - |
- - |
| 2015 | -11.84% 60/151 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 宏利转型机遇股票A VS. 东吴新产业精选股票A(580008) |